[{"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0594-2021", "product_description": "Corgard (nadolol tablets, USP) 40 mg 100 Tablets Rx only NDC 27505-101-01 Distributed by US WorldMeds, LLC, Louisville, KY 40241", "product_quantity": "2 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "19T28"}, {"status": "Terminated", "city": "Smyrna", "state": "TN", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["M007"], "brand_name": ["CITROMA"], "generic_name": ["MAGNESIUM CITRATE"], "manufacturer_name": ["Krogers"], "product_ndc": ["30142-899"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["MAGNESIUM CITRATE"], "spl_id": ["36b0308e-2206-31d0-e063-6394a90a4578"], "spl_set_id": ["2bcab227-42b6-4bff-8363-f6800665755b"], "package_ndc": ["30142-899-38"], "is_original_packager": [true], "unii": ["RHO26O1T9V"], "upc": ["041260001826"]}, "product_type": "Drugs", "event_id": "90599", "recalling_firm": "Vi-Jon, LLC", "address_1": "1 Swan Dr", "address_2": "", "postal_code": "37167-2099", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA as well as Canada and Panama.", "recall_number": "D-1503-2022", "product_description": "Kroger, Magnesium Citrate SALINE LAXATIVE, Oral Solution, 1.745 g, Lemon Flavor, 10 FL OZ (296 mL), Distributed By The Kroger CO Cincinnati, Ohio 45202;  NDC 30142-899-38 UPC 0 41260 00182 6", "product_quantity": "44,976 bottles", "reason_for_recall": "Microbial contamination of non-sterile products.", "recall_initiation_date": "20220715", "center_classification_date": "20220909", "termination_date": "20240509", "report_date": "20220921", "code_info": "Lot# 0557622, EXP 1/12/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Newtown", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA210510"], "brand_name": ["ATOVAQUONE ORAL SUSPENSION"], "generic_name": ["ATOVAQUONE"], "manufacturer_name": ["KVK-Tech, Inc."], "product_ndc": ["10702-223"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOVAQUONE"], "rxcui": ["308429"], "spl_id": ["116f0b5b-cbad-8216-e063-6294a90a9a13"], "spl_set_id": ["b31ff20a-c363-4be0-9bc0-3081c163b63c"], "package_ndc": ["10702-223-21"], "is_original_packager": [true], "upc": ["0310702223219"], "nui": ["N0000175482", "N0000175485"], "pharm_class_epc": ["Antimalarial [EPC]", "Antiprotozoal [EPC]"], "unii": ["Y883P1Z2LT"]}, "product_type": "Drugs", "event_id": "88220", "recalling_firm": "KVK-Tech, Inc.", "address_1": "110 Terry Dr", "address_2": "N/A", "postal_code": "18940-3427", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to one distributor who may have further distributed Nationwide in the USA.", "recall_number": "D-0772-2021", "product_description": "Atovaquone Oral Suspension, USP, 750 mg/5 mL, 210 mL bottle, Rx Only, Mfd. By: KVK-Tech, Inc., Newtown, PA  18940, NDC 10702-223-21.", "product_quantity": "1,692 bottles", "reason_for_recall": "Temperature abuse: the firm received customer complaints of unusual grittiness in the product.", "recall_initiation_date": "20210702", "center_classification_date": "20210826", "termination_date": "20220523", "report_date": "20210901", "code_info": "Batch # 16653A, 16654A, Exp 12/2022"}, {"country": "United States", "city": "Little Rock", "address_1": "1527 S Bowman Rd Ste D", "reason_for_recall": "Lack of Assurance of Sterility: Sterility of product is not assured.", "address_2": "", "product_quantity": "6 Bags", "code_info": "Compounded on 05/29/15, Discard After: 06/10/15", "center_classification_date": "20150701", "distribution_pattern": "United States including: Arkansas", "state": "AR", "product_description": "Vancomycin HCl in Dextrose, VANCOMYCIN 750mg / D5W 150mL, Qty: 6 150 mL Bags, Rx Only.  Compounded by: United Medical IV Center (Little Rock) 1527 South Bowman Rd. Ste. D Little Rock, AR 72211-4200.", "report_date": "20150708", "classification": "Class II", "openfda": {}, "recalling_firm": "Lincare, Inc.", "recall_number": "D-1172-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71415", "termination_date": "20170216", "more_code_info": "", "recall_initiation_date": "20150528", "postal_code": "72211-4200", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Berwyn", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA022430"], "brand_name": ["TRANEXAMIC ACID"], "generic_name": ["TRANEXAMIC ACID"], "manufacturer_name": ["Nordic Pharma, Inc."], "product_ndc": ["69918-301"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TRANEXAMIC ACID"], "rxcui": ["883826"], "spl_id": ["7bafece1-f0b8-4852-92ca-fe2bf261be04"], "spl_set_id": ["031bf7c2-3b07-469d-bc5a-31fc6238e25f"], "package_ndc": ["69918-301-30"], "is_original_packager": [true], "nui": ["N0000175634", "N0000175632"], "pharm_class_epc": ["Antifibrinolytic Agent [EPC]"], "pharm_class_pe": ["Decreased Fibrinolysis [PE]"], "unii": ["6T84R30KC1"]}, "product_type": "Drugs", "event_id": "92458", "recalling_firm": "Amring Pharmaceuticals Inc", "address_1": "1205 Westlakes Dr Ste 275", "address_2": "N/A", "postal_code": "19312-2411", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0871-2023", "product_description": "Lysteda (tranexamic acid) USP Tablets, 650 mg, 30 tablets per bottle, Rx Only, Manufactured for: Amring Pharmaceuticals Inc. Berwyn, PA 19312, NDC 69918-301-30", "product_quantity": "48,989 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.", "recall_initiation_date": "20230612", "center_classification_date": "20230614", "termination_date": "20240529", "report_date": "20230621", "code_info": "Lots: X220317A and X220318A, exp. date 09/25"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0266-2020", "product_description": "S-HCG/B12A 1000U/5MG/ML MDV INJ, packaged in a) 5ML b) 10 ML glass vials, Rx Only, Red Mountain Compounding Rx.", "product_quantity": "11x 5ml and 10ml glass vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #: a)  S06112019DH@10, Exp 8/11/19; b) S06112019DH@10, Exp 8/11/19,  S06142019DH@03, Exp 8/14/19, S06252019DH@14, Exp 8/25/19, S07222019DH@02, Exp 9/22/19,"}, {"country": "United States", "city": "Edmond", "address_1": "14844 Bristol Park Blvd", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date.", "address_2": "", "product_quantity": "2,940 pellets", "code_info": "lot#  C211 Exp. date 10/03/2018; C257 Exp. date 12/14/2018 and lot # D001 exp. date 01/02/19", "center_classification_date": "20180629", "distribution_pattern": "Nationwide in the USA", "state": "OK", "product_description": "ESTRADIOL 20mg PELLET, 1-count 3ml amber vial. RX only. Compounded by: Qualgen 14844 Bristol Park Blvd, Edmond OK 73013. NDC 69761-020-01", "report_date": "20180711", "classification": "Class III", "openfda": {}, "recalling_firm": "Qualgen, LLC", "recall_number": "D-0892-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80203", "termination_date": "20201125", "more_code_info": "", "recall_initiation_date": "20180608", "postal_code": "73013-1891", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: VERAPAMIL HCL ER, Capsule, 240 mg may have potentially been mislabeled as the following drug:  FEBUXOSTAT, Tablet, 40 mg, NDC 64764091830, Pedigree: W002664, EXP: 6/5/2014.", "address_2": "", "product_quantity": "100 Capsules", "code_info": "VERAPAMIL HCL ER, Capsule, 240 mg has the following codes:   Pedigree: W002665, EXP: 6/5/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "VERAPAMIL HCL ER, Capsule, 240 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378644001.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-908-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Whippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M005"], "brand_name": ["LOTRIMIN DAILY PREVENTION DEO"], "generic_name": ["TOLNAFTATE"], "manufacturer_name": ["Bayer HealthCare LLC."], "product_ndc": ["11523-0010"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["TOLNAFTATE"], "rxcui": ["705934"], "spl_id": ["289dbd00-e2f2-0998-e063-6394a90ae1a4"], "spl_set_id": ["9e8bfb78-ad81-93d0-e053-2995a90aa41d"], "package_ndc": ["11523-0010-1", "11523-0010-2"], "is_original_packager": [true], "unii": ["06KB629TKV"], "upc": ["041100587206", "041100589613"]}, "product_type": "Drugs", "event_id": "88677", "recalling_firm": "Bayer Healthcare Pharmaceuticals Inc.", "address_1": "100 Bayer Blvd", "address_2": "N/A", "postal_code": "07981-1544", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the US, Puerto Rico, Canada and Mexico through a variety of retail channels.", "recall_number": "D-0240-2022", "product_description": "LOTRIMIN AF (Tolnaftate 1%) DAILY PREVENTION deodorant powder spray, NET WT 160g (5.6 OZ) can, packaged as (a) single pack, UPC 0 41100 58720 6, NDC 11523-0010-2; (b) 3-pack, UPC 0 41100 58961 3; Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Finland,", "product_quantity": "579,456 cans", "reason_for_recall": "cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.", "recall_initiation_date": "20211001", "center_classification_date": "20211118", "termination_date": "20230626", "report_date": "20211124", "code_info": "Lot # (a)TN0023C, EXP 1/31/2022; TN003C7, EXP 4/30/2022; TN00570, EXP 7/31/2022; TN0056Z, TN005KJ, EXP 8/31/2022;  (b)TN0023C, EXP 01/31/2022; TN003C7, EXP 04/30/2022; TN0023DV, TN0023DAV, TN0023DBV, TN0023DC, EXP 02/28/2022; TN005KJ, TN005KJA, TN005KJB, EXP 08/31/2022;", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0668-2020", "product_description": "BAC 200MCG/BUP22MG/CLON210MCG/HYDROM 15MG/SUF800MCG/ML ML INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12172019@3 Exp. 12/26/2019", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; BENAZEPRIL HCL Tablet, 5 mg may be potentially mislabeled as    ZINC SULFATE, Capsule, 220 mg, NDC 60258013101, Pedigree: AD52993_34, EXP: 5/20/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "BENAZEPRIL HCL Tablet, 5 mg has the following code    Pedigree: AD52778_7, EXP: 5/20/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "BENAZEPRIL HCL Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 65162075110", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-712-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "North York", "state": "N/A", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83871", "recalling_firm": "Apotex Inc.", "address_1": "150 Signet Drive", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0316-2020", "product_description": "Equate Maximum Strength Ranitidine Tablets, USP 150 mg Acid Reducer 130 Tablets Distributed by Wal-Mart Stores, Inc. Bentonville, AR 72716 a) Twin Pack NDC: 49035-100-07; b) Single Pack NDC: 49035-100-00", "product_quantity": "1,132,453 bottles", "reason_for_recall": "GGMP Deviations: Possible contamination with impurity N-nitrosodimethylamine (NDMA).", "recall_initiation_date": "20190924", "center_classification_date": "20191112", "report_date": "20191120", "code_info": "All lots remaining within expiry."}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; ARIPiprazole Tablet, 2 mg may be potentially mislabeled as    tiZANidine HCl, Tablet, 2 mg, NDC 55111017915, Pedigree: AD21790_40, EXP: 5/1/2014;  ATOMOXETINE HCL, Capsule, 80 mg, NDC 00002325030, Pedigree: AD30140_19, EXP: 5/7/2014;  OLANZapine, Tablet, 7.5 mg, NDC 55111016530, Pedigree: AD46265_46, EXP: 5/15/2014;  REPAGLINIDE, Tablet, 2 mg, NDC 00169008481, Pedigree: AD464", "address_2": "", "product_quantity": "180 Tablets", "code_info": "ARIPiprazole, Tablet, 2 mg has the following codes    Pedigree: AD21790_43, EXP: 5/1/2014;  Pedigree: AD30140_25, EXP: 5/7/2014;  Pedigree: AD46265_19, EXP: 5/15/2014;  Pedigree: AD46414_1, EXP: 5/16/2014;  Pedigree: W003004, EXP: 6/11/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ARIPiprazole Tablet, 2 mg, Rx only, Distributed by: AidaPak Service, LLC,  NDC 59148000613", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-639-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-176-2014", "product_description": "Lipotonix Plus 30ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "1505 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075240"], "brand_name": ["LABETALOL HYDROCHLORIDE"], "generic_name": ["LABETALOL HYDROCHLORIDE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-0125", "0409-2267"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["LABETALOL HYDROCHLORIDE"], "rxcui": ["896771"], "spl_id": ["54801b0d-200b-4df2-92f0-b5b787c4fb8b"], "spl_set_id": ["abfc6b75-1ed5-41f1-0484-4597488237bc"], "package_ndc": ["0409-2267-20", "0409-2267-54", "0409-0125-01", "0409-0125-25"], "is_original_packager": [true], "unii": ["1GEV3BAW9J"]}, "product_type": "Drugs", "event_id": "68296", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-1424-2014", "product_description": "Labetalol Hydrochloride Injection, USP, 100 mg/20 mL (5 mg/mL), 20 mL Multidose Vial, packaged 50/20 mL glass vials/carton, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-2267-20", "product_quantity": "45,448 vials", "reason_for_recall": "Presence of Particulate Matter; metal embedded in the glass vial and visible particles floating in the solution", "recall_initiation_date": "20140516", "center_classification_date": "20140708", "termination_date": "20170316", "report_date": "20140716", "code_info": "Lot 36225DD, exp 12/01/2015", "more_code_info": ""}, {"status": "Terminated", "city": "Monroe Township", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA021357"], "brand_name": ["MULTIHANCE"], "generic_name": ["GADOBENATE DIMEGLUMINE"], "manufacturer_name": ["BRACCO DIAGNOSTICS INC"], "product_ndc": ["0270-5164"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["GADOBENATE DIMEGLUMINE"], "spl_id": ["0e7d3da8-78fa-b4ae-4a43-15919e900ebe"], "spl_set_id": ["59077a3e-5f03-4342-ae24-856267545631"], "package_ndc": ["0270-5164-12", "0270-5164-13", "0270-5164-14", "0270-5164-15"], "is_original_packager": [true], "unii": ["3Q6PPC19PO"]}, "product_type": "Drugs", "event_id": "62636", "recalling_firm": "Bracco Diagnostics Inc", "address_1": "259 Prospect Plains Rd.", "address_2": "Building H", "postal_code": "08831", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1663-2012", "product_description": "Bracco Diagnostics multihance (gadobenate dimeglumine) injection, 529 mg/mL, 20ml, Rx only, Manufactured for: Bracco Diagnostics Inc., Princeton, NJ 08543 USA, NDC 0270-5164-15", "product_quantity": "47,750 vials", "reason_for_recall": "Short Fill:  The product is being recalled due to a potential underfill of the affected vials.", "recall_initiation_date": "20120416", "center_classification_date": "20120827", "termination_date": "20130708", "report_date": "20120905", "code_info": "Lot S1P272A  Expiry Date: December 2014"}, {"status": "Ongoing", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA761062"], "brand_name": ["EVENITY"], "generic_name": ["ROMOSOZUMAB-AQQG"], "manufacturer_name": ["Amgen Inc"], "product_ndc": ["55513-880", "55513-998"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["ROMOSOZUMAB"], "rxcui": ["2123184", "2123185", "2123190", "2123191"], "spl_id": ["112895a2-37db-4ca8-afa6-34585bfb685b"], "spl_set_id": ["471baba2-7154-4488-9891-0db2f46791e7"], "package_ndc": ["55513-880-01", "55513-880-02", "55513-998-01", "55513-998-02"], "is_original_packager": [true], "unii": ["3VHF2ZD92J"]}, "product_type": "Drugs", "event_id": "97110", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Within the U.S - OH, VA, FL.", "recall_number": "D-0539-2025", "product_description": "EVENITY, (romosozumab -aqqg) injection, 105mg/1.17 mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-880-02.", "product_quantity": "2 Pre-filled syringes", "reason_for_recall": "CGMP Deviations; potential temperature excursions due to transit delays", "recall_initiation_date": "20250421", "center_classification_date": "20250721", "report_date": "20250730", "code_info": "Lot: 1178382, Expiration date: 3/31/2027"}, {"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0215-2023", "product_description": "HYDROXOCOBALAMIN-PF- 1MG/ML (1ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "t20221116@36 t20221117@11 t20221111@61", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210574"], "brand_name": ["CEFIXIME"], "generic_name": ["CEFIXIME"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-584"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEFIXIME"], "rxcui": ["409823"], "spl_id": ["30690cba-b831-45c1-b799-a013d6cfc2db"], "spl_set_id": ["6f1df975-f825-4301-87da-d7eba56a6890"], "package_ndc": ["67877-584-50", "67877-584-01", "67877-584-05", "67877-584-33"], "is_original_packager": [true], "unii": ["97I1C92E55"]}, "product_type": "Drugs", "event_id": "88982", "recalling_firm": "Ascend Laboratories LLC", "address_1": "339 Jefferson Rd Ste 101", "address_2": "N/A", "postal_code": "07054-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0229-2022", "product_description": "Cefixime Capsules 400 mg, 50 capsules bottles, Rx Only, Manufactured by: Alken Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories LLC, Parsippany, NJ, 07054  NDC 67877-584-50", "product_quantity": "4104 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20211103", "center_classification_date": "20211109", "termination_date": "20221221", "report_date": "20211117", "code_info": "Lot 20140282, exp Dec 2021", "more_code_info": ""}, {"status": "Ongoing", "city": "Amman", "state": "", "country": "Jordan", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92974", "recalling_firm": "AMMAN PHARMACEUTICAL INDUSTRIES", "address_1": "Building 108", "address_2": "Street A3, King Abdullah Ii Industrial City", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two (2) direct accounts in RI and CO.", "recall_number": "D-1153-2023", "product_description": "TRP Natural Eyes, Allergy Relief PF, Sterile Eye Drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-097-19.", "product_quantity": "8,810 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230901", "center_classification_date": "20230915", "report_date": "20230927", "code_info": "Lot: FT001; EXP: 07/24", "more_code_info": ""}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA018657"], "brand_name": ["METRONIDAZOLE"], "generic_name": ["METRONIDAZOLE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-1055"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["METRONIDAZOLE"], "rxcui": ["311683"], "spl_id": ["3e7d4d73-778e-4e49-bd5b-2c70c5c92488"], "spl_set_id": ["d2112f37-5080-4a19-bcc3-6386b49abe1d"], "package_ndc": ["0338-1055-48"], "is_original_packager": [true], "nui": ["N0000175435", "M0014907"], "pharm_class_epc": ["Nitroimidazole Antimicrobial [EPC]"], "pharm_class_cs": ["Nitroimidazoles [CS]"], "unii": ["140QMO216E"]}, "product_type": "Drugs", "event_id": "73118", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "1 Baxter Pkwy", "address_2": "N/A", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0863-2016", "product_description": "Metronidazole Injection USP, 500 mg per 100 mL (5 mg/mL), 100mL Sterile Single Dose Container bag, Rx only, Baxter USA, Product Code 2B3421, NDC 0338-1055-48.", "product_quantity": "334,560 bags", "reason_for_recall": "Presence of Particulate Matter: identified as a cloth fiber.", "recall_initiation_date": "20160121", "center_classification_date": "20160523", "termination_date": "20180226", "report_date": "20160601", "code_info": "Lot #: P339135, Exp 08/31/2017"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0699-2020", "product_description": "BUP 30MG/ FENT 400MCG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12132019@3 Exp. 12/22/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72746", "recalling_firm": "Sentara Enterprises", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "U.S. Including: VA, NC", "recall_number": "D-0640-2016", "product_description": "Solu-Cortef (hydrocortisone) 1MG in NS, Packaged in 0.1ML Syringe, Rx Only. SENTARA HOME HEALTH SENTARA RX, 535 Independence Pkwy ste.300, Chesapeake, VA 23320-5176.", "product_quantity": "9 Bags", "reason_for_recall": "Lack of Assurance of Sterility: Product sterility cannot be guaranteed.", "recall_initiation_date": "20150918", "center_classification_date": "20160128", "termination_date": "20160629", "report_date": "20160203", "code_info": "All Lots compounded between 11-Sep-15 and 17-Sep-15. Expiries: 28-Sep-15, 30-Sep-15"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; LUBIPROSTONE Capsule, 24 mcg may be potentially mislabeled as    ARIPiprazole, Tablet, 2 mg, NDC 59148000613, Pedigree: AD21790_43, EXP: 5/1/2014;  CYANOCOBALAMIN, Tablet, 1000 mcg, NDC 00904421713, Pedigree: AD21846_46, EXP: 5/1/2014;  VALSARTAN, Tablet, 160 mg, NDC 00078035934, Pedigree: AD39858_1, EXP: 5/16/2014.", "address_2": "", "product_quantity": "180 Capsules", "code_info": "LUBIPROSTONE Capsule, 24 mcg has the following codes    Pedigree: AD21790_46, EXP: 5/1/2014;  Pedigree: AD21811_1, EXP: 5/1/2014;  Pedigree: AD46312_1, EXP: 5/16/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LUBIPROSTONE Capsule, 24 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 64764024060", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-697-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: ACETAMINOPHEN/ BUTALBITAL/ CAFFEINE, Tablet, 325 mg/50 mg/40 mg may have potentially been mislabeled as the following drug:  ASPIRIN, Tablet, 325 mg, NDC 49348000123, Pedigree: W002640, EXP: 6/4/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "ACETAMINOPHEN/ BUTALBITAL/ CAFFEINE, Tablet, 325 mg/50 mg/40 mg has the following codes:   Pedigree:  W002654, EXP: 6/4/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ACETAMINOPHEN/ BUTALBITAL/ CAFFEINE, Tablet, 325 mg/50 mg/40 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00603254421.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-982-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Humacao", "state": "PR", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021436"], "brand_name": ["ABILIFY"], "generic_name": ["ARIPIPRAZOLE"], "manufacturer_name": ["Otsuka America Pharmaceutical, Inc."], "product_ndc": ["59148-006", "59148-007", "59148-008", "59148-009", "59148-010", "59148-011"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ARIPIPRAZOLE"], "rxcui": ["349490", "349545", "349547", "349553", "352307", "352308", "352309", "352310", "402131", "404602", "602964", "615172"], "spl_id": ["1b189d15-798d-4bed-a93d-a543ed7abd81"], "spl_set_id": ["c040bd1d-45b7-49f2-93ea-aed7220b30ac"], "package_ndc": ["59148-006-13", "59148-006-92", "59148-007-13", "59148-007-35", "59148-007-94", "59148-008-13", "59148-008-35", "59148-008-95", "59148-009-13", "59148-009-35", "59148-009-95", "59148-010-13", "59148-010-35", "59148-011-13", "59148-011-35"], "is_original_packager": [true], "nui": ["N0000175430"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "unii": ["82VFR53I78"]}, "product_type": "Drugs", "event_id": "63706", "recalling_firm": "Bristol Myers Squibb Manufacturing Company", "address_1": "Rd #3 Km 77.5", "address_2": "N/A", "postal_code": "00792", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "LA, TN, CA", "recall_number": "D-181-2013", "product_description": "ABILIFY (aripiprazole) Tablets, 30 mg, Rx only, Blister Pack of 100 tablets, Otsuka America Pharmaceutical Inc., Bristol-Myers Squibb NDC 59148-011-35", "product_quantity": "21 blister packs", "reason_for_recall": "CGMP Deviations: A drum of Abilify 30 mg Tablets rejected during the compression stage was not segregated from the other portion of the lot and was inadvertently shipped, packaged and distributed.", "recall_initiation_date": "20121102", "center_classification_date": "20130304", "termination_date": "20130502", "report_date": "20130313", "code_info": "2E69023A, Exp. FEB 28 2015"}, {"status": "Terminated", "city": "Ridgefield", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021395"], "brand_name": ["SPIRIVA"], "generic_name": ["TIOTROPIUM BROMIDE"], "manufacturer_name": ["Boehringer Ingelheim Pharmaceuticals, Inc."], "product_ndc": ["0597-0075"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL", "RESPIRATORY (INHALATION)"], "substance_name": ["TIOTROPIUM BROMIDE MONOHYDRATE"], "rxcui": ["485032", "580261"], "spl_id": ["902426f3-c843-416d-a1e3-b64eafc1f32d"], "spl_set_id": ["820839ef-e53d-47e8-a3b9-d911ff92e6a9"], "package_ndc": ["0597-0075-41", "0597-0075-75", "0597-0075-47"], "is_original_packager": [true], "unii": ["L64SXO195N"]}, "product_type": "Drugs", "event_id": "78775", "recalling_firm": "Boehringer Ingelheim Pharmaceuticals, Inc.", "address_1": "900 Ridgebury Rd", "address_2": "", "postal_code": "06877-1058", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed nationwide", "recall_number": "D-0242-2018", "product_description": "SPIRIVA HandiHaler (tiotropium bromide inhalation powder) 18 mcg/capsule  (90 capsules (unit dose blisters) per box, Rx Only, Made in Germany, Distributed by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877, NDC 0597-0075-47", "product_quantity": "45,008 units/90 capsules each unit", "reason_for_recall": "Failed Stability Specifications", "recall_initiation_date": "20171214", "center_classification_date": "20180126", "termination_date": "20181017", "report_date": "20180207", "code_info": "Lot # 606478; Exp. 03/18", "more_code_info": ""}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89798", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0693-2022", "product_description": "Lidocaine Cream, 4%, packaged in a) Net Wt. 15 grams tubes, NDC 52565-122-15; b) Net Wt. 30 grams tubes, NDC 52565-122-30; c) 5 x 5 gram tubes, NDC 52565-122-07; Manufactured by: Teligent Pharma, Inc. Buena, New Jersey 08310; Manufactured by: Teligent Pharma, Inc., Buena, New Jersey 08310.", "product_quantity": "136,960 tubes", "reason_for_recall": "cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.", "recall_initiation_date": "20220315", "center_classification_date": "20220321", "termination_date": "20240617", "report_date": "20220330", "code_info": "Batch: a) 15192, Exp. 2/28/2022; 16278, Exp. 1/31/2023; b) 15124, 15192, Exp. 2/28/2022; 15296, 15336, 15337, 15439, Exp. 3/31/2022; 16278, Exp. 1/31/2023; 16603, 16664, Exp. 3/31/2023;17023, Exp. 6/30/2023; c) 15067, Exp. 2/28/2022; 16664, Exp. 3/31/2023"}, {"status": "Ongoing", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA203016"], "brand_name": ["TOLTERODINE TARTRATE"], "generic_name": ["TOLTERODINE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-6593", "0904-6592"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TOLTERODINE TARTRATE"], "rxcui": ["855182", "855189"], "spl_id": ["29bf12b7-e530-4337-a021-ca7138b39d78"], "spl_set_id": ["da9423b5-00ab-46fc-8959-3db3c0a0bc6d"], "package_ndc": ["0904-6592-04", "0904-6593-04"], "original_packager_product_ndc": ["13668-189", "13668-190"], "unii": ["5T619TQR3R"]}, "product_type": "Drugs", "event_id": "96416", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0304-2025", "product_description": "Tolterodine Tartrate Extended-Release Capsules, 2 mg, 30 Capsules (3 x 10) Unit Dose carton, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6592-04.", "product_quantity": "224 cartons", "reason_for_recall": "Failed Dissolution Specifications: Out of specification results obtained during routine stability testing for dissolution.", "recall_initiation_date": "20250304", "center_classification_date": "20250328", "report_date": "20250409", "code_info": "Lot# T05393, Exp. Date: 09/30/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA203752"], "brand_name": ["MINIVELLE"], "generic_name": ["ESTRADIOL"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-6610", "68968-6625", "68968-6637", "68968-6650", "68968-6675"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["ESTRADIOL"], "rxcui": ["241946", "242891", "242892", "248478", "1149632", "1356979", "1356997", "1357007", "1357009", "1551622"], "spl_id": ["58e55d14-a9df-4814-9b60-b7c9ce37b0b7"], "spl_set_id": ["6c5c47ab-28ee-11e1-bfc2-0800200c9a66"], "package_ndc": ["68968-6625-8", "68968-6637-8", "68968-6650-8", "68968-6675-8", "68968-6610-8", "68968-6610-1"], "is_original_packager": [true], "nui": ["M0447348", "N0000175825", "N0000000100"], "pharm_class_cs": ["Estradiol Congeners [CS]"], "pharm_class_epc": ["Estrogen [EPC]"], "pharm_class_moa": ["Estrogen Receptor Agonists [MoA]"], "unii": ["4TI98Z838E"]}, "product_type": "Drugs", "event_id": "80033", "recalling_firm": "Noven Pharmaceuticals, Inc.", "address_1": "11960 SW 144th St", "address_2": "N/A", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0862-2018", "product_description": "Minivelle (estradiol transdermal system) 0.1 mg/day, 1 System per pouch (NDC 68968-6610-1), packaged in 8 pouches per box (NDC 68968-6610-8), Rx only, Mfd. by: Noven Pharmaceuticals, Inc., Miami, Florida 33186; Dist. by: Noven Therapeutics, LLC, Miami, Florida 33186.", "product_quantity": "61960 boxes", "reason_for_recall": "Defective Delivery System: no longer meets the specification for shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.", "recall_initiation_date": "20180504", "center_classification_date": "20180613", "termination_date": "20200604", "report_date": "20180516", "code_info": "Lot #: 81391, 81638 Exp. 10/18"}, {"status": "Terminated", "city": "Edison", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA022362"], "brand_name": ["WELCHOL"], "generic_name": ["COLESEVELAM HYDROCHLORIDE"], "manufacturer_name": ["Daiichi Sankyo Inc."], "product_ndc": ["65597-902", "65597-701", "65597-903", "65597-209", "65597-210", "65597-208"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["COLESEVELAM HYDROCHLORIDE"], "rxcui": ["866900", "866903", "866905", "866907", "866910", "866912", "2123384", "2123387"], "spl_id": ["3e806127-4a87-41cc-9b17-a77e20bb2452"], "spl_set_id": ["4a06d3b2-7229-4398-baba-5d0a72f63821"], "package_ndc": ["65597-701-18", "65597-903-60", "65597-902-30", "65597-209-30", "65597-210-30", "65597-208-30"], "is_original_packager": [true], "upc": ["0365597902305"], "unii": ["P4SG24WI5Q"]}, "product_type": "Drugs", "event_id": "68793", "recalling_firm": "Daiichi Sankyo Pharma Development", "address_1": "399 Thornall St", "address_2": "", "postal_code": "08837-2236", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1505-2014", "product_description": "Welchol Tablets (colesevelam HCl) 625 mg, 180 count bottles, Rx Only, Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 ---NDC 65597-701-18", "product_quantity": "68 bottles", "reason_for_recall": "Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping", "recall_initiation_date": "20140712", "center_classification_date": "20140731", "termination_date": "20150316", "report_date": "20140806", "code_info": "Lot NVWG Exp - 11/30/2016", "more_code_info": ""}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202692"], "brand_name": ["OFLOXACIN OPHTHALMIC"], "generic_name": ["OFLOXACIN"], "manufacturer_name": ["Altaire Pharmaceuticals Inc."], "product_ndc": ["59390-140"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["OFLOXACIN"], "rxcui": ["312075"], "spl_id": ["28125c1a-d1b0-4763-9b5e-07b4cfc2d889"], "spl_set_id": ["fe564e33-8f5d-4b57-87a9-7afae02eaf97"], "package_ndc": ["59390-140-05"], "is_original_packager": [true], "nui": ["N0000175937", "M0023650"], "pharm_class_epc": ["Quinolone Antimicrobial [EPC]"], "pharm_class_cs": ["Quinolones [CS]"], "unii": ["A4P49JAZ9H"], "upc": ["593901400517"]}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0436-2020", "product_description": "Ofloxacin Ophthalmic Solution, USP, 0.3%, 5 mL, Rx only, Altaire Pharmaceuticals, Inc., NDC 59390-140-05", "product_quantity": "102,939 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "17244 8/19   18057 3/20   518307 12/20"}, {"status": "Terminated", "city": "San Francisco", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73662", "recalling_firm": "Reliable Rexall-A Compounding Pharmacy", "address_1": "801 Irving St", "address_2": "N/A", "postal_code": "94122-2310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S. Including: CA, HI, NM", "recall_number": "D-1136-2016", "product_description": "All Malarone (atovaquone and proguanil) Products, Rx Only, Compounded by RELIABLE DRUG/RELIABLE COMPOUNDING PHARMACY, 801 Irving St., SAN FRANCISCO, CA 94122.", "product_quantity": "N/A", "reason_for_recall": "Lack of Processing Controls", "recall_initiation_date": "20160325", "center_classification_date": "20160706", "termination_date": "20170410", "report_date": "20160713", "code_info": "All lots compounded between 03/24/2015 and 03/24/2016 and within expiry.."}, {"status": "Terminated", "city": "Huntsville", "state": "AL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72397", "recalling_firm": "Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals", "address_1": "150 Vintage Dr NE", "address_2": "N/A", "postal_code": "35811-8216", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0232-2016", "product_description": "HYDROCHLOROTHIAZIDE CAPSULES, USP, 12.5 mg, 3000 count bottles, Rx only, Manufactured for: Qualitest Pharmaceuticals, Inc., Huntsville, AL 35811, NDC: 0603-3855-93.", "product_quantity": "912 HDPE bottles", "reason_for_recall": "Presence of Particulate Matter.", "recall_initiation_date": "20151007", "center_classification_date": "20151113", "termination_date": "20161116", "report_date": "20151125", "code_info": "T084M14A, T085M14A, T086M14A; Exp 12/16"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62461", "recalling_firm": "Church & Dwight Inc", "address_1": "469 N Harrison St", "address_2": "N/A", "postal_code": "08540-3510", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-061-2013", "product_description": "Orajel Kids My Way! Anticavity Fluoride (sodium fluoride) toothpaste, 0.24%, 3 oz (85 g) pump, Church & Dwight Col, Inc., Princeton, NJ  08543; UPC 3 10310 32370 7.", "product_quantity": "42,768 pumps", "reason_for_recall": "CGMP Deviations: Product was made with an incorrect ingredient, Laureth-9 was mistakenly substituted for PEG.", "recall_initiation_date": "20120906", "center_classification_date": "20121121", "termination_date": "20130611", "report_date": "20121128", "code_info": "Lot #: BI1041, Exp 02/13"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0069-2015", "product_description": "Chorionic gonadotropin buffered diluent solution packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "500 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 03182014@24, Exp 9/14/2014; 04012014@31, Exp 9/28/2014; 06032014@30, Exp 11/30/2014; 07292014@28, Exp 1/25/2015", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0957-2023", "product_description": "EPINEPHrine, 2 mg added to dextrose 5% 250mL, Concentration = 8 mcg/mL, IV Bag, Rx Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-6030-1.", "product_quantity": "333 Bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-251702, Exp. 8/29/2023"}, {"status": "Terminated", "city": "Corvallis", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82278", "recalling_firm": "Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy", "address_1": "996 Nw Circle Blvd Ste 105", "address_2": "N/A", "postal_code": "97330-1485", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed in Oregon", "recall_number": "D-1105-2019", "product_description": "PAPAVERINE-PHENTOLAMINE-PGE1 22.5-0.8MG-8.3MCG/ML INJECTABLE, 5 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .", "product_quantity": "2 prescriptions, 5ml injection", "reason_for_recall": "Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.", "recall_initiation_date": "20190221", "center_classification_date": "20190409", "termination_date": "20200723", "report_date": "20190417", "code_info": "Lot:26112018@68, 13122018@12, distributed between 09-01-2018 to 02-20-2019."}, {"country": "United States", "city": "Ft Lauderdale", "address_1": "1458 NW 23rd Ave", "reason_for_recall": "Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined that the products was found to contain sildenafil, an undeclared active pharmaceutical ingredient.", "address_2": "", "product_quantity": "", "code_info": "All lots", "center_classification_date": "20140320", "distribution_pattern": "Nationwide and France", "state": "FL", "product_description": "Clalis capsules, 50 mg, 6 -count bottle ( labeling is in foreign language)", "report_date": "20140326", "classification": "Class I", "openfda": {}, "recalling_firm": "Fabscout Entertainment, Inc", "recall_number": "D-1169-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65892", "termination_date": "20191002", "more_code_info": "", "recall_initiation_date": "20130627", "postal_code": "33311-5147", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Hasbrouck Heights", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA090170"], "brand_name": ["LAMOTRIGINE"], "generic_name": ["LAMOTRIGINE"], "manufacturer_name": ["Unichem Pharmaceuticals (USA), Inc."], "product_ndc": ["29300-111", "29300-112", "29300-113", "29300-114"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LAMOTRIGINE"], "rxcui": ["198427", "198428", "198429", "282401"], "spl_id": ["03f59daf-b60e-46d1-b121-6a39361ee4f3"], "spl_set_id": ["4b72ea7a-a0b0-4980-84ad-84f64e2e6368"], "package_ndc": ["29300-111-01", "29300-111-05", "29300-111-10", "29300-112-01", "29300-112-05", "29300-112-10", "29300-113-16", "29300-113-05", "29300-113-10", "29300-114-16", "29300-114-05", "29300-114-10"], "is_original_packager": [true], "upc": ["0329300113167", "0329300111019", "0329300114164"], "nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "unii": ["U3H27498KS"]}, "product_type": "Drugs", "event_id": "75205", "recalling_firm": "Unichem Pharmaceuticals Usa Inc", "address_1": "777 Terrace Ave", "address_2": "Suite 102", "postal_code": "07604-3102", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1519-2016", "product_description": "Lamotrigine Tablets, USP, 150 mg, 500-count Tablets per bottle, Rx only,  Manufactured by: Unichem Laboratories LTD., Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511 India; Marketed by: Unichem Pharmaceuticals (USA), Inc ., Rochelle Park, NJ 07662; NDC 29300-113-05.", "product_quantity": "368 bottles", "reason_for_recall": "Tablets/Capsules Imprinted With Wrong ID: incorrect imprint debossed on the tablets.", "recall_initiation_date": "20160819", "center_classification_date": "20160923", "termination_date": "20170207", "report_date": "20161005", "code_info": "Lot #: GLEH 16003, Exp 03/31/18"}, {"status": "Ongoing", "city": "Rochester", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA204485"], "brand_name": ["VASOSTRICT"], "generic_name": ["VASOPRESSIN"], "manufacturer_name": ["ENDO USA, Inc."], "product_ndc": ["42023-164", "42023-190", "42023-219", "42023-220", "42023-237", "42023-268"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["VASOPRESSIN, UNSPECIFIED"], "rxcui": ["313578", "1593738", "2103182", "2103184", "2399907", "2399909", "2399913", "2399915", "2591428", "2591431", "2670680", "2670683"], "spl_id": ["ae4fb2c4-03cd-49b1-8d50-b3ec733478f4"], "spl_set_id": ["b1147beb-743e-4c62-8927-91192447f8b8"], "package_ndc": ["42023-164-01", "42023-164-25", "42023-164-10", "42023-190-01", "42023-219-01", "42023-219-10", "42023-220-01", "42023-220-10", "42023-237-01", "42023-237-10", "42023-268-01", "42023-268-10"], "is_original_packager": [true], "upc": ["0342023157010"], "unii": ["Y87Y826H08"]}, "product_type": "Drugs", "event_id": "93805", "recalling_firm": "Par Sterile Products LLC", "address_1": "870 Parkdale Rd", "address_2": "N/A", "postal_code": "48307-1740", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0232-2024", "product_description": "Vasostrict (vasopressin in 5% Dextrose) Injection, 20 units per 100 mL (0.2 units per mL), 100 mL x 10 Single Dose Vials per carton, Ready to Use, For Intravenous Infusion, Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977.  NDC: 42023-237-10", "product_quantity": "1721 cartons", "reason_for_recall": "Superpotent Drug: Assay from the 3-month and 6-month stability intervals exceeded the upper specification limit.", "recall_initiation_date": "20240111", "center_classification_date": "20240116", "report_date": "20240124", "code_info": "Lot # 66702; Exp. 02/2025"}, {"country": "United States", "city": "Berkeley", "address_1": "2320 Woolsey St", "reason_for_recall": "Lack of Assurance of Sterility: Firm is recalling all unexpired lots of sterile compounded products after FDA inspection found concerns of lack of sterility assurance.", "address_2": "", "product_quantity": "25 ml", "code_info": "All lots", "center_classification_date": "20160217", "distribution_pattern": "CA", "state": "CA", "product_description": "papaverine phentolamine prostaglandin; 25/0.83 mg/20 mcg/mL;  5 mL and 10 mL unit sizes, refrigerate, This Rx is Compounded, Abbott's Compounding Pharmacy, Berkeley, CA 94705", "report_date": "20160224", "classification": "Class II", "openfda": {}, "recalling_firm": "Abbott's Compounding Pharmacy, Inc.", "recall_number": "D-0701-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73090", "termination_date": "20170406", "more_code_info": "", "recall_initiation_date": "20160115", "postal_code": "94705-1973", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Morelia", "state": "N/A", "country": "Mexico", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87917", "recalling_firm": "DIBAR NUTRICIONAL S DE RL DE CV", "address_1": "Sargento Manuel De La Rosa #145", "address_2": "Col Chapultepec Sur", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0644-2021", "product_description": "DiBAR LABS Hand Sanitizer (ethyl alcohol 70%), 8 FL OZ. (236.5 mL), Distributed by S.E.N.D. LLC, Anthony, NM 88021, Imported by Dibar Labs, LLC, Sugar Land, TX 77479, Made in Mexico,77479, NDC 73009-0001-08 UPC 8 53090 00301 3.", "product_quantity": "Unknown quantity", "reason_for_recall": "Chemical Contamination: FDA analysis found 3 lots of DiBAR hand Sanitizer to be below the label claim for ethanol content and to contain methanol.", "recall_initiation_date": "20210511", "center_classification_date": "20210629", "termination_date": "20230308", "report_date": "20210707", "code_info": "Lot # LDHSN050920 T1, LDHSN051020 DESC, LDHSN051020 T2, EXP 05/2022"}, {"status": "Terminated", "city": "New Paltz", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89464", "recalling_firm": "Ultra Seal Corporation", "address_1": "521 Main St", "address_2": "N/A", "postal_code": "12561-1609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0478-2022", "product_description": "Multi Symptom Cold Relief (acetaminophen 325 mg, Dextromethorphan HBr 15mg, Guaifenesin 200mg, Phenylephrine HCl 5mg) tablets, 2-count packets, Dist. by Honeywell Safety Products USA, Smithfield, RI 02917", "product_quantity": "673,160 packets", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220124", "center_classification_date": "20220131", "termination_date": "20231016", "report_date": "20220209", "code_info": "Lot #: AK9715, K9715, Exp. Date 07/2022"}, {"status": "Terminated", "city": "Wilton", "state": "CT", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88770", "recalling_firm": "Beiersdorf Inc", "address_1": "45 Danbury Rd", "address_2": "N/A", "postal_code": "06897-4405", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0012-2022", "product_description": "Coppertone Pure & Simple baby 50 Sunscreen Spray (To Deliver) Zinc Oxide 24.08%, NET WT 5 OZ (142 g) can, Beiersdorf Inc., Wilton, CT 06897  UPC 0 72140 02881 7", "product_quantity": "124,668 cans", "reason_for_recall": "Chemical contamination; presence of benzene", "recall_initiation_date": "20210930", "center_classification_date": "20211015", "termination_date": "20230413", "report_date": "20211027", "code_info": "Lot# TN0083J, exp. date 01/31/2023 TN0083K, exp. date 01/31/2023"}, {"status": "Terminated", "city": "Ridgefield", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA204629"], "brand_name": ["JARDIANCE"], "generic_name": ["EMPAGLIFLOZIN"], "manufacturer_name": ["Boehringer Ingelheim Pharmaceuticals, Inc."], "product_ndc": ["0597-0152", "0597-0153"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["EMPAGLIFLOZIN"], "rxcui": ["1545658", "1545664", "1545666", "1545668"], "spl_id": ["2669be16-3d07-4426-a711-aac76ce3d3c9"], "spl_set_id": ["faf3dd6a-9cd0-39c2-0d2e-232cb3f67565"], "package_ndc": ["0597-0152-90", "0597-0152-07", "0597-0152-70", "0597-0152-37", "0597-0152-30", "0597-0153-37", "0597-0153-30", "0597-0153-90", "0597-0153-07", "0597-0153-70"], "is_original_packager": [true], "nui": ["N0000187059", "N0000187058"], "pharm_class_epc": ["Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"], "pharm_class_moa": ["Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "unii": ["HDC1R2M35U"]}, "product_type": "Drugs", "event_id": "91879", "recalling_firm": "Boehringer Ingelheim Pharmaceuticals, Inc.", "address_1": "900 Ridgebury Rd", "address_2": "N/A", "postal_code": "06877-1058", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide within the United States and PR", "recall_number": "D-0468-2023", "product_description": "JARDIANCE (Empagliflozin), 25 mg Tablets, packaged in a) 30-count (NDC0597-0153-30) and b) 90-count (NDC 0597-0153-90) bottles, Rx only, Marketed by: Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, CT 06877 USA and Eli Lilly and Company Indianapolis, IN 46285 USA", "product_quantity": "69,375 bottles", "reason_for_recall": "Labeling: Label Mix-up", "recall_initiation_date": "20230309", "center_classification_date": "20230317", "termination_date": "20231204", "report_date": "20230329", "code_info": "Lot #: a) and b) E61835, exp. date JUN 2025"}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "5582.6 mL", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #s: 09242013@8, 09242013@3, 09242013@4, 09242013@6, 09242013@7, 09242013@9, 10012013@1, 10012013@2, 10012013@3, 10012013@4, 10012013@5, 10012013@6, 10032013@6, 10142013@1", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "Neomycin Sulfate* ophthalmic solution, 333 mg/mL, all sizes, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI 48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-435-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-503-2015", "product_description": "Adenosine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "1000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89331", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "N/A", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to one direct account in PA.", "recall_number": "D-0366-2022", "product_description": "Metformin 750 mg Extended Release  NDC # 70518-2920-00", "product_quantity": "56 Blister Cards", "reason_for_recall": "CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.", "recall_initiation_date": "20211230", "center_classification_date": "20220111", "termination_date": "20220328", "report_date": "20220119", "code_info": "Lot #  J0511265-021121, exp. date 02/28/2022   J0499451-122220, exp. date 01/31/2022   J0496563-120820, exp. date 12/31/2021   J0495111-120120, exp. date 12/31/2021"}, {"status": "Terminated", "city": "New Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77398", "recalling_firm": "Spectrum Laboratory Products, Inc.", "address_1": "755 and 769 Jersey Ave", "address_2": "N/A", "postal_code": "08901-3605", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0881-2017", "product_description": "Estradiol (17-B-Estradiol; Estra-1,3,5(10)-triene-3, 17B-diol; Oestradiol) Plant Base, Micronized, U.S.P active pharmaceutical ingredient, packaged in 1g, 5g, 25g, 6 x 25g, and 100g containers, Rx only, Spectrum Chemical Mfg. Corp, Gardena, CA  90248, New Brunswick, NJ  08901, Product code E1435.", "product_quantity": "48 containers", "reason_for_recall": "CGMP Deviations: these repackaged and redistributed products are being recalled due to a recall notice from the active pharmaceutical ingredient manufacturer for deviations from current Good Manufacturing Practices that were found during a recent FDA inspection.", "recall_initiation_date": "20170413", "center_classification_date": "20170602", "termination_date": "20190221", "report_date": "20170614", "code_info": "Lot #: 2FH0257, Exp 09/30/2017;  2GA0254, Exp 03/24/2018"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019885"], "brand_name": ["ACCUPRIL"], "generic_name": ["QUINAPRIL HYDROCHLORIDE"], "manufacturer_name": ["Parke-Davis Div of Pfizer Inc"], "product_ndc": ["0071-0527", "0071-0530", "0071-0532", "0071-0535", "0071-1205", "0071-1410", "0071-1620", "0071-1840"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["QUINAPRIL HYDROCHLORIDE"], "rxcui": ["207891", "207892", "207893", "207895", "312748", "312749", "312750", "314203"], "spl_id": ["ee20d3b1-a5c8-4510-a931-3872df7b77f4"], "spl_set_id": ["63cf5651-d52c-4d27-9fd4-ed9cd9724dff"], "package_ndc": ["0071-0527-23", "0071-0530-23", "0071-0530-40", "0071-0532-23", "0071-0532-40", "0071-0535-23", "0071-1205-23", "0071-1410-23", "0071-1620-23", "0071-1840-23"], "is_original_packager": [true], "upc": ["0300710527232", "0300710532236", "0300711620239", "0300711410236", "0300711840231", "0300710535237", "0300710530232", "0300711205238"], "unii": ["33067B3N2M"]}, "product_type": "Drugs", "event_id": "90064", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0873-2022", "product_description": "Accupril (Quinapril HCl Tablets) 20 mg,  90 Tablets, Rx only NDC 0071-0532-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017", "product_quantity": "10,304 bottles", "reason_for_recall": "CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.", "recall_initiation_date": "20220422", "center_classification_date": "20220516", "termination_date": "20231005", "report_date": "20220525", "code_info": "Lots: DX8682 Exp. MAR 31 2023; DG1188 Exp. MAR 31 2022", "more_code_info": ""}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83136", "recalling_firm": "Infusion Options, Inc.", "address_1": "5924 13th Ave", "address_2": "N/A", "postal_code": "11219-4934", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY only", "recall_number": "D-1761-2019", "product_description": "Cyclophosphamide 840 MG / 250 ML NS IVPB; Cyclophosphamide 1112 MG / 250 ML NS IVPB; Cyclophosphamide 1248 MG / 50 ML NS IVPB; Cyclophosphamide 1125 MG / 100 ML NS IVPB; Cyclophosphamide 1000 MG / 500 ML NS IVPB; Cyclophosphamide 1400 MG / 100 ML NS IVPB  Cyclophosphamide 1056 MG / 250 ML NS IVPB; Cyclophosphamide 980 MG / 500 ML NS IVPB; Cyclophosphamide 580 mg / 500 ML NS IVPB; Cyclophosphamide 880 MG / 500 ML NS IVPB; Cyclophosphamide 501 MG / 250 ML NS IVPB; Cyclophosphamide 1163 MG / 50 ML NS IVPB  Cyclophosphamide 1100 MG / 500 ML NS IVPB; Cyclophosphamide 1152 MG / 250 ML NS IVPB; Cyclophosphamide 1116 MG / 250 ML NS IVPB  Cyclophosphamide 894 MG / 250 ML NS IVPB; Cyclophosphamide 1210 MG / 500 ML NS IVPB; Cyclophosphamide 1010 MG/ 500 ML NS IVPB  Cyclophosphamide 1030 MG / 500 ML NS IVPB; Cyclophosphamide 500 MG / 250 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190612", "center_classification_date": "20190815", "termination_date": "20250321", "report_date": "20190821", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77319", "recalling_firm": "VistaPharm, Inc.", "address_1": "7265 Ulmerton Rd", "address_2": "", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US and Puerto Rico", "recall_number": "D-0869-2017", "product_description": "Nystatin Oral Suspension, USP, 100,000 units/mL, packaged in a) 2 fl.oz. (60mL) bottles (NDC 66689-008-02), and 500,000 units/5mL individual unit dose cup (NDC 66689-037-01) packaged in b) 50 count unit dose cups/case (NDC 66689-037-50) and c) 100 count unit dose cups/case (NDC 66689-037-99) Rx only, Manufactured by: VistaPharm, Largo, FL 33771.", "product_quantity": "2,208,500 cups/18696 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Presence of an impurity peak that exceeds approved specification.", "recall_initiation_date": "20170517", "center_classification_date": "20170531", "termination_date": "20200113", "report_date": "20170607", "code_info": "a) Lot #: 431300, Exp. 01/2018;   b) Lot #: 434000, 432500, Exp. 07/2017;462200, Exp. 02/2018  c) Lot #: 443800, 445500, Exp. 09/2017; 460500, 461500, Exp. 01/2018.", "more_code_info": ""}, {"status": "Ongoing", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213368"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-7129", "0904-7130", "0904-7131", "0904-7132", "0904-7133"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["be5824c1-1eca-44db-a689-c67b9808c1f9"], "spl_set_id": ["d58570a0-58b0-4662-b2ad-aa8d1463b4c1"], "package_ndc": ["0904-7129-61", "0904-7130-61", "0904-7130-06", "0904-7131-61", "0904-7132-61", "0904-7133-61", "0030904713"], "original_packager_product_ndc": ["70710-1129", "70710-1130", "70710-1131", "70710-1132", "70710-1133"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97584", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0013-2026", "product_description": "Major ChlorproMAZINE Hydrochloride Tablets, USP, 200 mg, 100 Tablets (10x10) blister package, Rx Only, Packaged and Distributed by Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-7133-61, UPC (01)00309047133611  NDC 0904-7133-61", "product_quantity": "1394 blister packs", "reason_for_recall": "CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit", "recall_initiation_date": "20250912", "center_classification_date": "20251007", "report_date": "20251015", "code_info": "Lots N01928, Exp. Date, 09/30/2025, N02008, Exp. Date, 03/21/2026 & N02071, Exp. Date 02/28/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88764", "recalling_firm": "Eli Lilly & Company", "address_1": "839 S Delaware St", "address_2": "N/A", "postal_code": "46225-1782", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide with the USA and Puerto Rico; Canada, Argentina, Costa Rica, Mexico", "recall_number": "D-0009-2022", "product_description": "Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection, 1 mg per vial; Diluent for Glucagon, 1 mL syringe. Rx only, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285; Glucagon, NDC: 0002-8031-01", "product_quantity": "19,174 syringes", "reason_for_recall": "SUBPOTENT DRUG: Vial contained a liquid substance, instead of the expected powder substance.  There was also a lack of full drug effect upon administration.", "recall_initiation_date": "20210924", "center_classification_date": "20211014", "termination_date": "20240906", "report_date": "20211020", "code_info": "Lot #: D239382D, Exp. Date April 2022"}, {"status": "Terminated", "city": "Tampa", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83996", "recalling_firm": "Coast Quality Pharmacy, LLC dba Anazao Health", "address_1": "5710 Hoover Blvd", "address_2": "N/A", "postal_code": "33634-5339", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0582-2020", "product_description": "Baclofen and Morphine Sulfate in all strengths, all doses and all packaging, AnazaoHealth 5710 Hoover Blvd Tampa, FL 33634.", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi.", "recall_initiation_date": "20190903", "center_classification_date": "20191206", "termination_date": "20201201", "report_date": "20191218", "code_info": "All lots filled 08/26/2019 and dispensed 08/26-29/2019 remaining within expiry.", "more_code_info": ""}, {"status": "Terminated", "city": "Sugar Land", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77634", "recalling_firm": "PharMedium Services, Llc", "address_1": "12620 W Airport Blvd Ste 130", "address_2": "N/A", "postal_code": "77478-6200", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0990-2017", "product_description": "Potassium PHOSphate in 0.9% Sodium Chloride Injection, 40 mMol in 250 mL in 250 mL Intravia Bag, Rx Only, PharMEDium Services, LLC 12620 W. Airport Blvd #130 Sugar Land, TX 77478 800-523-7749 Service Code 2K5301 NDC# 61553-301-11", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; media fill failure at manufacturer", "recall_initiation_date": "20170626", "center_classification_date": "20170714", "termination_date": "20200429", "report_date": "20170726", "code_info": "Lots: 171220007S Exp. 7/31/2017, 171280129S Exp. 8/7/2017, 171320112S Exp. 8/13/2017, 171590010S Exp. 9/7/2017"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA016620"], "brand_name": ["NITROFURANTOIN MACROCRYSTALS"], "generic_name": ["NITROFURANTOIN MACROCRYSTALS"], "manufacturer_name": ["Alvogen Inc."], "product_ndc": ["47781-306", "47781-307", "47781-308"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NITROFURANTOIN"], "rxcui": ["311994", "311995", "1648759"], "spl_id": ["97785cf3-ab56-4697-3ab6-7451919d889a"], "spl_set_id": ["62c1bb9c-79a2-41e3-9dfa-352f92253881"], "package_ndc": ["47781-306-01", "47781-307-01", "47781-308-01"], "is_original_packager": [true], "upc": ["0347781307011", "0347781306014", "0347781308018"], "nui": ["N0000175494", "M0014892"], "pharm_class_epc": ["Nitrofuran Antibacterial [EPC]"], "pharm_class_cs": ["Nitrofurans [CS]"], "unii": ["927AH8112L"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0421-2021", "product_description": "Nitrofurantoin Macrocrystals Capsules 25 mg 100 Capsules Rx Only NDC 47781-306-01 Manufactured by: Norwich Pharmaceuticals, Inc. Norwich, NY 13815 Distributed by: Alvogen, Inc. Parsippany, NJ 07054 U.S.A.", "product_quantity": "15 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "486942"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "249 ml", "code_info": "All lots distributed between November 2014 and May 2015;  03042015@17, 6/2/2015; 04142015@20, 7/13/2015; 03192015@51, 6/17/2015; 04142015@89, 7/13/2015; 04232015@3, 7/22/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Lipotropic B-12 Injection, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1691-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1672-2019", "product_description": "LIDOCAINE HCL 2% INJECTION SOLUTION (NPV), 20ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0172-20", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0268-2020", "product_description": "S-HYDROXOCOBALAMIN 1000MCG/ML MDV INJ; packaged in a) 10ML b) 30ML glass vial, Red Mountain Compounding Rx", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #:a) S07162019DT@04, Exp 10/16/19; b) S07162019DT@04 Exp 10/16/19"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "29 mL Total volume", "code_info": "All lots distributed between November 2014 and May 2015;  05012015@13, 5/31/2015, 05012015@16, 5/31/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Clotrimazole 2% Otic Suspension, ml, Sterile, Room Temperature, Shake Well, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1454-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0140-2022", "product_description": "QUAD-MIX PAPAV 30/PHENTOL 2/PGE-1 30/ATROPINE 0.2 INJ   INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "3 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 08182021:31 BUD: 02/08/2022; 08262021:69 BUD: 02/08/2022; 08052021:40 BUD: 11/30/2021", "more_code_info": ""}, {"country": "United States", "city": "Oklahoma City", "address_1": "755 Research Pkwy Ste 150", "reason_for_recall": "Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.", "address_2": "", "product_quantity": "", "code_info": "all lot codes", "center_classification_date": "20140729", "distribution_pattern": "Nationwide", "state": "OK", "product_description": "Dermamedics Calm and Correct Cream 2 oz. containers in the Dermamedics Post Medical Procedure Kit with a SKU number of SK1005", "report_date": "20140806", "classification": "Class II", "openfda": {}, "recalling_firm": "Dermamedics, L.L.C.", "recall_number": "D-1493-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "67247", "termination_date": "20170314", "more_code_info": "", "recall_initiation_date": "20140110", "postal_code": "73104-3621", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73899", "recalling_firm": "Baptist Health Medical Towers Pharmacy and Infusion Services", "address_1": "9601 Baptist Health Dr Ste 109", "address_2": "N/A", "postal_code": "72205-6323", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Arkansas", "recall_number": "D-0913-2016", "product_description": "70% Ethanol-lock Solution, 2 mL Syringe, FOR IV USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock, AR", "product_quantity": "18 syringes", "reason_for_recall": "Lack of Sterility Assurance", "recall_initiation_date": "20160418", "center_classification_date": "20160529", "termination_date": "20161223", "report_date": "20160608", "code_info": "All product remaining within expiry"}, {"country": "United States", "city": "Monroe Township", "address_1": "259 Prospect Plains Road", "reason_for_recall": "Presence of Particulate Matter; fibers identified as cellulose and polyvinyl", "address_2": "Building H", "product_quantity": "5483 syringes (548.3 boxes)", "code_info": "Lot #: 9K37791, Exp 11/12; 9L40746, Exp 12/12; 0A43705, Exp 01/13; 0C57509, 0C57521, Exp 03/13; 0E62913, Exp 05/13", "center_classification_date": "20130207", "distribution_pattern": "Nationwide.", "state": "NJ", "product_description": "Isovue -370 (Iopamidol) Injection 76%, Prefilled 10 x 75 mL (NDC 0270-1316-66), 10 x 100 mL (NDC 0270-1316-67), 10 x 125 mL (NDC 0270-1316-68) Power Injector Syringe, Rx Only, Manufactured for Bracco Diagnostics Inc., Princeton, NJ 08543 by Nycomed GmbH 78224 Singen (Germany).", "report_date": "20130213", "classification": "Class I", "openfda": {}, "recalling_firm": "Bracco Diagnostic Inc", "recall_number": "D-157-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "63765", "termination_date": "20150706", "more_code_info": "", "recall_initiation_date": "20121121", "postal_code": "08831", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Karodi", "state": "", "country": "India", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "80356", "recalling_firm": "Wockhardt Limited", "address_1": "H - 14/2 Plot", "address_2": "Biotech Park", "postal_code": "N/A", "voluntary_mandated": "", "initial_firm_notification": "", "distribution_pattern": "Nationwide.", "recall_number": "D-0913-2018", "product_description": "Enalapril Maleate Tablets USP; 2.5 mg NDC code 64679-923-03. 1000 Tablets HDPE container pack with Non CRC cap and 2 desiccants further packed in E-flute cartons.", "product_quantity": "17,628 tablets", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20180619", "center_classification_date": "20180709", "termination_date": "20200413", "report_date": "20180718", "code_info": "Batch# DR10447 (Exp: 4/19); Batch# DR10996 (Exp: 10/19); Batch# DS10201 (Exp: 2/20); and Batch# DR10319 (Exp: 3/20).", "more_code_info": ""}, {"status": "Terminated", "city": "Ridgefield", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020850"], "brand_name": ["MICARDIS"], "generic_name": ["TELMISARTAN"], "manufacturer_name": ["Boehringer Ingelheim Pharmaceuticals, Inc."], "product_ndc": ["0597-0041", "0597-0039", "0597-0040"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TELMISARTAN"], "rxcui": ["205304", "205305", "213431", "213432", "282755", "284531"], "spl_id": ["333f0ca9-928d-45af-92b9-9ea8a4d02f7d"], "spl_set_id": ["cfb9309f-e0df-4a55-9542-0e869fce05fb"], "package_ndc": ["0597-0039-37", "0597-0040-37", "0597-0041-37"], "is_original_packager": [true], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["U5SYW473RQ"]}, "product_type": "Drugs", "event_id": "87856", "recalling_firm": "Boehringer Ingelheim Pharmaceuticals, Inc.", "address_1": "900 Ridgebury Rd", "address_2": "", "postal_code": "06877-1058", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "AR, CO, CT, LA, NC, ND, NH, NJ, OH, PA and PR", "recall_number": "D-0600-2021", "product_description": "Micardis Tablets, (telmisartan Tablets) 80 mg, 30 ct. per folding cartons, Rx only, NDC 0597-0041-37), Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877", "product_quantity": "15,198 bottles (30 tablets per bottle)", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20210504", "center_classification_date": "20210528", "termination_date": "20211014", "report_date": "20210609", "code_info": "Lot #860412; SEPT 2022", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88442", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed Nationwide, including Puerto Rico.", "recall_number": "D-0736-2021", "product_description": "Octreotide Acetate Injection 1000 mcg/5mL, 5 mL multi-dose vial, Rx only, Teva Pharmaceuticals USA. Inc. North Wales, PA 19454, NDC 0703-3333-01", "product_quantity": "16,644 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20210729", "center_classification_date": "20210816", "termination_date": "20240604", "report_date": "20210825", "code_info": "Lot #: 31329150B, exp. date 06/2022"}, {"country": "United States", "city": "Springerville", "address_1": "105 W Main St", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "4 containers", "code_info": "all lots", "center_classification_date": "20151201", "distribution_pattern": "Nationwide in US: Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah", "state": "AZ", "product_description": "Sodium Bicarbonate 8.4% Inj, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Western Drug", "recall_number": "D-0452-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "72520", "termination_date": "20161001", "more_code_info": "", "recall_initiation_date": "20151019", "postal_code": "85938-7203", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "86019", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W Field Ct Ste 300", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-1388-2020", "product_description": "Proparacaine Hydrochloride Ophthalmic Solution, USP, 0.5%, 15 mL per dropper bottle, Sterile, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045.  NDC 17478-263-12", "product_quantity": "33,343 bottles", "reason_for_recall": "Chemical contamination; out of specification results obtained for equipment cleaning residue rinse sample", "recall_initiation_date": "20191226", "center_classification_date": "20200714", "termination_date": "20220728", "report_date": "20200722", "code_info": "Lot 9E52A, exp 04/2021"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: FENOFIBRATE, Tablet, 54 mg may have potentially been mislabeled as the following drug:\t  FAMCICLOVIR, Tablet, 500 mg, NDC 00093811956, Pedigree: AD49448_4, EXP: 5/17/2014.", "address_2": "", "product_quantity": "90 Tablets", "code_info": "FENOFIBRATE, Tablet, 54 mg has the following codes:   Pedigree: AD49448_7, EXP: 5/17/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "FENOFIBRATE, Tablet, 54 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00115551110.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-860-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "Jenison", "state": "MI", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "85854", "recalling_firm": "MICHIGAN HERBAL REMEDIES", "address_1": "904 Chicago Dr", "address_2": "", "postal_code": "49428-9351", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide via internet sales,retailers and distributors in the USA", "recall_number": "D-1447-2020", "product_description": "Tasty Drops Hemp Oil Extract, Natural, 1 FL. OZ (30ML) bottles, 500mg CBD, Dist by: Tasty Hemp Oil, Jenison, MI,  UPC 6 96305 29084 2", "product_quantity": "220 bottles", "reason_for_recall": "Chemical Contamination: product contains elevated levels of undeclared lead.", "recall_initiation_date": "20200618", "center_classification_date": "20200804", "report_date": "20200812", "code_info": "FG003138 and FG003248", "more_code_info": ""}, {"status": "Terminated", "city": "Bronx", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "73018", "recalling_firm": "R Thomas Marketing, LLC", "address_1": "3704 White Plains Rd", "address_2": "N/A", "postal_code": "10467-5710", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide via Internet sales", "recall_number": "D-0903-2016", "product_description": "Night Man, packaged in SMALL BOX (6 capsules), Distributed by: R Thomas Marketing, LLC, Bronx, NY 10467", "product_quantity": "unknown", "reason_for_recall": "Marketed Without An Approved NDA/ANDA", "recall_initiation_date": "20160109", "center_classification_date": "20160526", "termination_date": "20190621", "report_date": "20160601", "code_info": "all lots"}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "89717", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "N/A", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA including Puerto Rico.", "recall_number": "D-0723-2022", "product_description": "Hydroxocobalamin B12 1mg/mL, Multi-Dose 30 mL vial, Each ML contains: 0.82% Sodium Chloride USP, 0.9% Benzyl Alcohol NF, Sterile Water for Injection USP, Rx Only,  Olympia Pharmaceuticals Conroy Rd., Ste. 155, Orlando, FL 32835 NDC 73198-0080-30", "product_quantity": "1613 vials", "reason_for_recall": "Sub Potent", "recall_initiation_date": "20220308", "center_classification_date": "20220329", "termination_date": "20231004", "report_date": "20220330", "code_info": "Lot: E47025 Exp. 5/21/22"}, {"status": "Terminated", "city": "Trujillo Alto", "state": "PR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91325", "recalling_firm": "Frenda Corporation", "address_1": "Calle A Lote 7 Parque Ind Las Cuevas", "address_2": "N/A", "postal_code": "00976", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Puerto Rico", "recall_number": "D-0254-2023", "product_description": "Easy Clean Antiseptic Hand Sanitizer Solution 65% with Glycerine, 1 Gallon (128 Fl. oz.),  Manufactured by: Frenda Corporation Trujillo Alto, PR 00976, UPC 8 91857 00050 9", "product_quantity": "144 bottles", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20221215", "center_classification_date": "20230130", "termination_date": "20240910", "report_date": "20230208", "code_info": "Lot: C013121"}, {"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0234-2023", "product_description": "PROSTAGLANDIN (PE1) 45MCG (1ML VIAL) INJECTABLE PROSTAGLANDIN E1 17MCG/ML (1ML VIAL) INJECTABLE PROSTAGLANDIN E1 20MCG/ML (1ML VIAL) INJECTABLE PROSTAGLANDIN E1 22.5MCG/ML (1ML VIAL) INJECTABLE PROSTAGLANDIN E1 23MCG/ML (1ML VIAL) INJECTABLE PROSTAGLANDIN E1 30MCG/ML (1ML VIAL) INJECTABLE PROSTAGLANDIN E1 40MCG/ML (1ML VIAL) INJECTABLE PROSTAGLANDIN E1 44.5MCG/ML (1ML VIAL) INJECTABLE PROSTAGLANDIN E1 45MCG/ML (3ML VIAL) INJECTABLE PROSTAGLANDIN E1 50MCG/ML (1ML VIAL) INJECTION PROSTAGLANDIN E1 60MCG/ML (1ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "t20221027@29 t20221020@25 t20221109@17 t20221118@8 t20221129@68 t20221027@11 t20221010@24 t20221010@61 t20221005@2 t20221024@22 t20221116@36 t20221004@12", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: DIGOXIN, Tablet, 0.125 mg may have potentially been mislabeled as one of the following drugs:   MELATONIN, Tablet, 3 mg, NDC 08770140813, Pedigree: AD21846_34, EXP: 5/1/2014;  DESMOPRESSIN ACETATE, Tablet, 0.1 mg, NDC 00591246401, Pedigree: AD46426_16, EXP: 5/15/2014;  PROPRANOLOL HCL, Tablet, 10 mg, NDC 00603548221, Pedigree: AD60264_1, EXP: 5/22/2014;  LIOTHYRONINE SODIUM,", "address_2": "", "product_quantity": "400 Tablets", "code_info": "DIGOXIN, Tablet, 0.125 mg has the following codes:   Pedigree: AD22609_4, EXP: 4/30/2014;  Pedigree: AD46426_22, EXP: 5/15/2014;  Pedigree: AD62829_8, EXP: 5/23/2014;  Pedigree: W003154, EXP: 6/13/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "DIGOXIN, Tablet, 0.125 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00115981101.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-861-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0051-2023", "product_description": "PRED ACETATE / GATIFLOXACIN 1% / 0.5% SUSP, 10 mL droptainers, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "378 droptainers", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lots: 65056, BUD: 11/18/2022; 66246, BUD: 11/19/2022"}, {"status": "Terminated", "city": "Jeannette", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80633", "recalling_firm": "Ranier's Compounding Laboratory", "address_1": "1107 Lowry Ave", "address_2": "", "postal_code": "15644-3030", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed within the state of Pennsylvania.", "recall_number": "D-1093-2018", "product_description": "P/P/P 0.02/40/2mg/mL(Prostaglandin//Papaverine/Phentolamine) Injection, 0.02/40/2 mg/mL, 1 mL vial, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.", "product_quantity": "1 vial", "reason_for_recall": "Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.", "recall_initiation_date": "20180725", "center_classification_date": "20180815", "termination_date": "20220901", "report_date": "20180822", "code_info": "All lots within expiry", "more_code_info": ""}, {"status": "Completed", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA207008"], "brand_name": ["CINACALCET"], "generic_name": ["CINACALCET"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["47335-379", "47335-380", "47335-600"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CINACALCET HYDROCHLORIDE"], "rxcui": ["432400", "432401", "432402"], "spl_id": ["fb601aec-aba6-4bec-a98d-51e556fef95c"], "spl_set_id": ["092553cf-1bcd-4c19-9adf-b46f2bda5c9e"], "package_ndc": ["47335-379-83", "47335-380-83", "47335-600-83"], "is_original_packager": [true], "upc": ["0347335600834"], "unii": ["1K860WSG25"]}, "product_type": "Drugs", "event_id": "93820", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0263-2024", "product_description": "Cinacalcet Tablets 60mg, Rx Only, 30 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited Survey No. 259/15, Dadra-396 191 (U.T. of D & NH), India, NDC 47335-380-83.", "product_quantity": "1,728 bottles", "reason_for_recall": "CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.", "recall_initiation_date": "20240118", "center_classification_date": "20240125", "report_date": "20240131", "code_info": "Lot #: DNE0702A, Exp. 06/30/2026"}, {"country": "United States", "city": "Mount Vernon", "address_1": "144 Kingsbridge Road East", "reason_for_recall": "Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.", "address_2": "", "product_quantity": "844,704 suppositories", "code_info": "Lot #: 1310001, 13J04, 1310167, 1311013, 1312008, 1401055, 13S02, 14A05, 1402061, 14C01, 14C05, 14C06, 14E02, 1405081, 1406107, 1407062, 14096751, 14096752, 14096753, 15026752, 15026752, 15046752, 15066752, 15066753", "center_classification_date": "20151127", "distribution_pattern": "Nationwide", "state": "NY", "product_description": "GRx HiCort 25 (hydrocortisone acetate 25 mg) Suppositories, 12-count box, Rx only, Distributed by Geritrex Corporation  Mount Vernon, NY 10550, NDC 54162-015-12", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Geritrex Corp", "recall_number": "D-0392-2016", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "72509", "termination_date": "20180611", "more_code_info": "", "recall_initiation_date": "20151027", "postal_code": "10550", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93224", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "N/A", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0153-2024", "product_description": "Phenytoin Oral Suspension, USP, 100 mg/4 mL, packaged in packaged in 4 mL unit dose cups (NDC 0904-7079-24), 50 per case (NDC 0904-7079-57), Rx only, Major Pharmaceuticals Livonia, MI 48152", "product_quantity": "3718 saleable units", "reason_for_recall": "Failed Content Uniformity Specifications", "recall_initiation_date": "20231023", "center_classification_date": "20231220", "termination_date": "20240710", "report_date": "20231227", "code_info": "Lot# C00099, C00115 Exp. date: 07/31/2024; C00079 Exp. date: 12/31/2023"}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "2", "code_info": "B0020 Exp 8/20/13 and C31011 Exp 9/10/13", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Vitamin B12 (3000 mcg/ml & 5000 mcg/ml) Injection, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-791-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0333-2017", "product_description": "Nicotinamide Adenine Dinucleotide (NADH) - Lyophilized (P.F.) 100 mg Injectable, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "Unknown", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.       Known lot code: 03302016@13, 06302016@95, 08082016@58."}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76105", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide and Puerto Rico", "recall_number": "D-0478-2017", "product_description": "Lisinopril tablets, 5 mg, 1000-count bottle, Rx only, Manufactured for Accord Healthcare, Inc., Durham, NC 27703, NDC 16729-376-17", "product_quantity": "12896 bottles", "reason_for_recall": "Failed tablet/capsule specification: missing break line on the 5mg tablet.", "recall_initiation_date": "20161220", "center_classification_date": "20170216", "termination_date": "20170802", "report_date": "20170222", "code_info": "Lot # T04483, T04484, Exp 2/18; T06028, Exp 4/18; T08423, Exp 5/18", "more_code_info": ""}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0252-2018", "product_description": "Aplicare Povidone-Iodine Prep Pad, Antiseptic, Sterile Solution, Active Ingredient: Povidone-iodine USP 10%. Aplicare, INC., Meriden, CT 06450 USA. NDC: 52380-0111-1", "product_quantity": "11,750 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Part # P-1001;  Lots: 58471;  59003;  59723;  60373;  60807;  61187;  61523;  61998;  63974;  64701;  65864  Part # P-1001-8S  Lots: 58368;  58371;  58472;  58499;  58686;  58687;  58688;  58816;  58817;  58818;  59002;  59004;  59333;  59334;  59335;  59574;  59724;  59725;  60157;  60237;  60374;  60375;  60507;  60586;  61101;  61368;  61427;  61618;  61750;  61751;  61999;  62067;  62224;  62226;  62557;  62558;  62954;  62955;  63441;  63442;  63443;  63507;  63508;  64002;  64129;  64243;  64245;  64592;  64840;  65081;  65327;  65583;  65681;  65882;  66026;  66040;  66110;  66193;      Part # P-1011  Lots: 66549; 66916    Part # P-1011-8S  Lots: 66404;  66580;  66622;  66709;  66856", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; ISOSORBIDE MONONITRATE Tablet, 10 mg may be potentially mislabeled as    ASCORBIC ACID, Tablet, 250 mg, NDC 00904052260, Pedigree: AD28322_10, EXP: 5/6/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "ISOSORBIDE MONONITRATE Tablet, 10 mg has the following code    Pedigree: AD28352_1, EXP: 5/7/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ISOSORBIDE MONONITRATE Tablet, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 62175010601", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-669-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Wichita", "state": "KS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96232", "recalling_firm": "Fagron Compounding Services", "address_1": "8710 E 34th St N", "address_2": "N/A", "postal_code": "67226-2636", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed in PA", "recall_number": "D-0225-2025", "product_description": "fentaNYL Citrate In Sodium Chloride 1600mcg/100mL (16 mcg per mL) CII, Single use  100mL IV Bag, Fagron Sterile Services, 8710 E 34th St N, Wichita, KS 67726 Bar Code 71266-5060-01", "product_quantity": "1330 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250131", "center_classification_date": "20250219", "report_date": "20250226", "code_info": "Lot # C274-000040409, Exp 03/22/2025"}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0143-2016", "product_description": "TESTOSTERONE CYPIONATE FOR SUBQ INJECTION, Injectable Solution, 200 mg/mL, syringe size: 5ml and 10mL, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "243 (10mL) syringes, 5 (5mL) syringes", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t12312014@11, t10302014@9, t08062014@28, t05292015@30, t04282015@12, t04092015@22, t03302015@1, t03102015@29, t02172015@2, t01292015@18, 12082014@10, 11242014@5, 11122014@5, 10222014@24, 10012014@19, 09242014@7, 09152014@17, 08152014@27, 08042014@6, 07112014@23, 07082015@8, 06172015@14, 05272015@12, 05132015@12, 04082015@1, 03092015@11, 02232015@2."}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-577-2015", "product_description": "Chlorobutanol Anhydrous pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "13600 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0972-2019", "product_description": "Dr. King's SafeCare Rx Aller-Detox: Outdoor Pollution Control Homeopathic, 2 fl oz (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806 USA, UPC 357955240426, NDC 57955-2404-2", "product_quantity": "98 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 070815C Exp. 07/18; 070116A Exp. 06/19"}, {"status": "Ongoing", "city": "Lincoln", "state": "RI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M006"], "brand_name": ["ZAPZYT ACNE TREATMENT GEL"], "generic_name": ["BENZOYL PEROXIDE"], "manufacturer_name": ["Focus Consumer Healthcare, LLC"], "product_ndc": ["71687-0011"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["BENZOYL PEROXIDE"], "rxcui": ["486131"], "spl_id": ["2df18af1-0ee0-39d1-e063-6394a90ae62a"], "spl_set_id": ["6079d45c-dd86-6f2e-e053-2991aa0a9743"], "package_ndc": ["71687-0011-1"], "is_original_packager": [true], "upc": ["0010768001102"], "unii": ["W9WZN9A0GM"]}, "product_type": "Drugs", "event_id": "96384", "recalling_firm": "Denison Pharmaceuticals, LLC", "address_1": "1 Powder Hill Rd", "address_2": "", "postal_code": "02865-4407", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0273-2025", "product_description": "Zapzyt, Acne Treatment Gel, 10% benzoyl peroxide Gel, packaged in 1 oz (28.35g) tube, Distributed by: FOCUS CONSUMER HEALTHCARE, LLC., 801 Broad St Ste 200, Chattanooga, TN 37402. NDC 71687-0011-1", "product_quantity": "642,131 tubes", "reason_for_recall": "Chemical Contamination: Presence of benzene.", "recall_initiation_date": "20250224", "center_classification_date": "20250312", "report_date": "20250319", "code_info": "Lot #: 9762, Exp. Date 2/28/2025; 9763, 9764, 9765, Exp. Date 3/31/2025; 9869, 9870, Exp. Date 5/31/2025; 9871, 9872, Exp. Date 7/31/2025; 9996, 9997, 9998, Exp. Date 8/31/2025;  9995, Exp. Date 10/31/2025; 0154, 0153, 0326, Exp. Date 1/31/2026; 0155, 0156, 0161,  0327, 0329, 0328, Exp. Date 2/28/2026; 0479, 0480, Exp. Date 5/31/2026.", "more_code_info": ""}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75752", "recalling_firm": "VistaPharm, Inc.", "address_1": "7265 Ulmerton Rd", "address_2": "N/A", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0146-2017", "product_description": "Lactulose Solution, USP, 10 g/15 mL, 15 mL unit dose cups (NDC 66689-039-01), packaged in 15 mL x 50 unit dose cups per case (NDC 66689-039-50), Rx only, Manufactured by VistaPharm, Inc., Largo, FL 33771.", "product_quantity": "1497 cases", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: bulk solution tested positive for the presence of the bacteria, Burkholderia cepacia.", "recall_initiation_date": "20161109", "center_classification_date": "20161122", "termination_date": "20210924", "report_date": "20161130", "code_info": "Lot No. 378300, Exp 11/16"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77862", "recalling_firm": "Pfizer Inc.", "address_1": "235 E 42nd St", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1163-2017", "product_description": "Quillivant XR methylphenidate HCl, for extended-release oral suspension, 600 mg/120 mL total volume (When constituted with 105 mL of water, 25 mg/5 mL (5 mg/mL) when reconstituted,   Rx Only, Distributed by Nextwave Pharmaceuticals, Inc. A subsidiary of Pfizer Inc., New York, NY 10017, Manufactured by Tris Pharma, Inc., Monmouth Junction, NJ 08852, NDC 24478-200-20.", "product_quantity": "14,712 bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20170804", "center_classification_date": "20170915", "termination_date": "20190411", "report_date": "20170927", "code_info": "Lot # 03216048A, Exp.  05/18", "more_code_info": ""}, {"country": "United States", "city": "Birmingham", "address_1": "6801 Cahaba Valley Rd Ste 116", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "187 mL in Vials", "code_info": "Lot #: 151130-48, BUD: 05/26/16;  Lot #: 151215-7, BUD: 05/26/16;  Lot #: 151216-12, BUD: 05/26/16;  Lot #: 160106-27, BUD: 05/26/16;  Lot #: 160113-38, BUD: 07/11/16;  Lot #: 160223-33, BUD: 07/31/16;  Lot #: 160307-36, BUD: 07/31/16;  Lot #: 160307-52, BUD: 07/31/16;  Lot #: 160308-5, BUD: 07/31/16", "center_classification_date": "20160708", "distribution_pattern": "U.S. Nationwide, Japan, and New Zealand.", "state": "AL", "product_description": "M.I.C. 25/50/50 (PF)  METHIONINE 25MG;INOSITOL 50MG;CHOLINE CHL 50MG/ML, In 2ML Vials, MEDAUS PHARMACY", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Medaus, Inc.", "recall_number": "D-1220-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "74466", "termination_date": "20170616", "more_code_info": "", "recall_initiation_date": "20160513", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "New Paltz", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89464", "recalling_firm": "Ultra Seal Corporation", "address_1": "521 Main St", "address_2": "N/A", "postal_code": "12561-1609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0499-2022", "product_description": "PAPENOL (acetaminophen 500 mg), 2 tablet packets, Manufactured for: Afassco Inc. Minden, NV 89423", "product_quantity": "533,100 packets", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220124", "center_classification_date": "20220131", "termination_date": "20231016", "report_date": "20220209", "code_info": "Lot #: K9495, Exp. Date 02/2022; AK9614, Exp. Date 05/2022"}, {"status": "Ongoing", "city": "Edmond", "state": "OK", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "97086", "recalling_firm": "Qualgen, LLC", "address_1": "14844 Bristol Park Blvd", "address_2": "N/A", "postal_code": "73013-1891", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States.", "recall_number": "D-0517-2025", "product_description": "Testosterone 200 mg Pellet packaged in 1mL amber vials, Rx only, Compounded product. Qualgen 14844 Bristol Park Blvd Edmond OK 73013, NDC 69761-202-01", "product_quantity": "2,832 amber vials", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp. Date: A printing issue resulted in incorrect lot numbers on the label.", "recall_initiation_date": "20250616", "center_classification_date": "20250714", "report_date": "20250723", "code_info": "Lot number: 1043, Exp. Date 2/10/2026"}, {"status": "Terminated", "city": "Somerset", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090019"], "brand_name": ["GAVILYTE-N"], "generic_name": ["POLYETHYLENE GLYCOL-3350, SODIUM CHLORIDE, POTASSIUM CHLORIDE AND SODIUM BICARBONATE"], "manufacturer_name": ["Lupin Pharmaceuticals,Inc."], "product_ndc": ["43386-050"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["POLYETHYLENE GLYCOL 3350", "POTASSIUM CHLORIDE", "SODIUM BICARBONATE", "SODIUM CHLORIDE"], "rxcui": ["801054", "979099"], "spl_id": ["3839c7fd-e7c4-45c6-ae02-0302b40046b0"], "spl_set_id": ["27195187-75a3-431f-90d9-84da1b94e849"], "package_ndc": ["43386-050-19", "3433860501", "3433862000", "3433862020", "3433862034"], "is_original_packager": [true], "nui": ["N0000010288", "N0000175811", "N0000009871"], "pharm_class_moa": ["Osmotic Activity [MoA]"], "pharm_class_epc": ["Osmotic Laxative [EPC]"], "pharm_class_pe": ["Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "unii": ["G2M7P15E5P", "660YQ98I10", "8MDF5V39QO", "451W47IQ8X"], "upc": ["343386050192", "343386200023", "343386202027"]}, "product_type": "Drugs", "event_id": "82396", "recalling_firm": "LUPIN SOMERSET", "address_1": "400 Campus Dr", "address_2": "N/A", "postal_code": "08873-1145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1113-2019", "product_description": "Gavilyte-N, PEG-3350, Sodium chloride, Sodium Bicarbonate and Potassium Chloride for Oral Solution, Rx only, Manufactured by Novel Laboratories, Inc. Somerset, NJ 08873 Manufactured for Lupin Pharmaceuticals, Inc. Baltimore, MD NDC 43386-050-19  UPC 343386050192    a) Lemon Flavor Pack net wt. 2 g UPC 343386200023  b) Orange Flavor Pack net wt. 2 g UPC 343386202027  c) Cherry Flavor Pack net wt. 2 g UPC 3433862034", "product_quantity": "76422 bottles", "reason_for_recall": "Labeling Not Elsewhere Classified; orange and cherry flavor packets incorrect list \"natural lemon flavor\" as an ingredient", "recall_initiation_date": "20190319", "center_classification_date": "20190409", "termination_date": "20220523", "report_date": "20190417", "code_info": "Lot #: a) S800021, Exp 30-Nov-20; b) S800175, Exp 31-Dec-20; c) S 800401, Exp 28-Feb-21; S800426, Exp 31-Mar-21; S800920, Exp 31-Aug-21."}, {"status": "Ongoing", "city": "Earth City", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82326", "recalling_firm": "Legacy Pharmaceutical Packaging LLC", "address_1": "13333 Lakefront Dr", "address_2": "N/A", "postal_code": "63045-1514", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Wal-Mart distribution centers in AR, CA, GA, IN and MD", "recall_number": "D-1048-2019", "product_description": "Losartan Potassium Tablets, USP, 25 mg, 30 tablet bottles, Rx Only, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045 NDC 68645-577-54", "product_quantity": "456,732 bottles", "reason_for_recall": "CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) detected", "recall_initiation_date": "20190301", "center_classification_date": "20190321", "report_date": "20190327", "code_info": "Lots: 180952, exp Oct-19, 180953, exp Dec-19, 181086, exp Sep-19, 181572, exp Jan-20"}]